Search results
Results From The WOW.Com Content Network
This ligament is responsible for maintaining and supporting the position of the eyeball in its normal upward and forward position within the orbit, and prevents downward displacement of the eyeball. [2] It can be considered a part of the bulbar sheath. [3] It is named for Charles Barrett Lockwood.
The "Lockwood's suspensory ligament" of the eye is named after him. This structure is the thickened area of contact between Tenon's capsule and the sheaths of the inferior rectus and inferior oblique muscles. This ligament is responsible for maintaining the position of the eyeball in its normal upward and forward position within the orbit.
Tenon's capsule (/ t ə ˈ n oʊ n /), also known as the Tenon capsule, fascial sheath of the eyeball (Latin: vagina bulbi) or the fascia bulbi, is a thin membrane which envelops the eyeball from the optic nerve to the corneal limbus, separating it from the orbital fat and forming a socket in which it moves.
A suspensory ligament is a ligament that supports a body part, especially an organ.. Types include: Suspensory ligament of axilla, also known as Gerdy's ligament; Cooper's ligaments, also known as the suspensory ligaments of Cooper or Suspensory ligaments of breast
Here, 2% xylocaine is introduced into the muscle cone behind the eyeball. The injection is usually given through the inferior fornix of the skin of the outer part of the lower lid when the eye is in primary gaze. The ciliary nerves, ciliary ganglion, oculomotor nerve and abducens nerve are anesthetized in retrobulbar block. [2]
Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor . [ 1 ] It is used to treat various eye diseases, such as age-related macular degeneration (AMD) , diabetic retinopathy , and infections inside the eye such as ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
In 1958, Balazs suggested the possibility of using hyaluronic acid as a substitute for the vitreous substitute during surgery for retinal detachment, and in 1972 made the first injection of hyaluronic acid into the vitreous chamber. [1] Ophthalmic viscosurgical devices were introduced in 1972. [6]